Skip to main content
TipRanks
Go Ultimate75% OFF

Bruker (BRKR) Capital Expenditure by Segment

493 Followers

Capital Expenditure by Segment

Tracks where Bruker is investing in plant, equipment, and infrastructure across its segments, indicating commitments to capacity expansion, product development, or maintenance. Large or sustained capex in a segment can point to future growth opportunities but also raises cash needs and execution risk.

-$10.00M$0.00$10.00M$20.00M$30.00MMar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26Sep 26
Chart Insights

CapEx is clearly lumpy and project‑driven: large 2024–25 investments in BioSpin and CALID have mostly run their course (BioSpin spending falling to near‑zero by mid‑2026), which should free cash and support the margin and leverage improvements management is pushing. Meanwhile NANO and CALID still show episodic big spend consistent with the company’s semiconductor/deep‑tech push — capex likely precedes revenue because of long lead times — and declining BEST spend suggests lower priority or consolidation in that business.

BRKR Capital Expenditure by Segment

DateCorporate & OtherBSI BioSpinBSI CALIDBSI NANOBEST
Sep 30, 2026$2.10M$0.00$0.00$6.70M$2.10M
Jun 30, 2026$3.50M$0.00$6.50M$7.50M$2.80M
Mar 31, 2026$2.30M$2.40M$6.70M$4.90M$1.60M
Dec 31, 2025$2.90M$1.10M$4.30M$15.30M$4.50M
Sep 30, 2025$1.50M$4.80M$7.10M$3.10M$2.10M
Jun 30, 2025$6.90M$2.30M$5.50M$13.20M$2.40M
Mar 31, 2025$4.70M$3.20M$8.40M$4.90M$4.80M
Dec 31, 2024$3.90M$6.00M$15.90M$4.80M$6.20M
Sep 30, 2024$4.20M$13.40M$6.50M$4.30M$4.20M
Jun 30, 2024$4.00M$3.80M$6.40M$4.00M$6.30M
Mar 31, 2024$2.70M-$400.00K$5.30M$6.20M$7.60M